Pomolic acid suppresses osteosarcoma growth and metastasis through the TNF/NF-κB-autophagy axis
Pathology - Research and Practice · 2026-09 · 285 · 156525
DOI: 10.1016/j.prp.2026.156525 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathology - Research and Practice, 2026-09. Verfasst von Shaolin Yu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, the First Affiliated Hospital, Fujian Medical University, Fuzhou 350005, China; Department of Orthopaedic Surgery,…. Hauptthemen laut MEDLINE: Osteosarcoma, Bone Neoplasms, NF-kappa B, Oleanolic Acid. Die Arbeit nennt 47 Literaturangaben. Gefördert von: Natural Science Foundation of Fujian Province, Fujian Medical University, National Natural Science Foundation of China.
Abstract (Originalsprache)
BACKGROUND: Osteosarcoma, the leading type of primary bone cancer in adolescents, has a dismal prognosis in metastatic or relapsed patients, highlighting the urgent need for innovative treatments. Pomolic acid (PA), a naturally occurring pentacyclic triterpenoid, exhibits anticancer potential, but its activity and mechanisms in osteosarcoma remain poorly defined. PURPOSE: This study focused on the antitumor effects of PA on osteosarcoma and elucidated the underlying molecular pathways, with additional performed in vivo. METHODS: Human osteosarcoma cell lines (143B and MG63) were used to examine the influence of PA on cell growth, apoptosis, cell cycle distribution, motility, invasion, and autophagy. Transcriptomic profiling was performed using RNA sequencing. An MG63 subcutaneous xenograft model was further utilized to assess therapeutic efficacy and safety in vivo. RESULTS: PA markedly inhibited osteosarcoma cell viability in a dose- and time- dependent manner, triggered G2/M phase arrest, and induced apoptosis. It also substantially reduced migration and invasion, likely through the reversal of epithelialmesenchymal transition (EMT). Transcriptomic data indicated that TNF/NF-κB signaling and autophagy pathways were modulated. In the xenograft model, PA treatment significantly suppressed tumor progression without evident toxicity. CONCLUSION: PA demonstrated robust anti-osteosarcoma activity in vitro and in vivo. Its mechanisms include blocking proliferation, inducing apoptosis and cell cycle arrest, attenuating metastatic behaviors linked to EMT, and modulating autophagy, possibly through interference with the TNF/NF-κB signaling axis. These findings suggest that PA is a promising candidate for osteosarcoma therapy, warranting further preclinical and clinical evaluation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopaedic Surgery, the First Affiliated Hospital, Fujian Medical University, Fuzhou 350005, China; Department of Orthopaedic Surgery, Jian Central People's Hospital, Jian 343000, China; Department of Ort…
- Department of Orthopaedic Surgery, the First Affiliated Hospital, Fujian Medical University, Fuzhou 350005, China; Department of Orthopaedic Surgery, National Regional Medical Center, Binhai Campus of the First Affiliat…
Förderung
- Natural Science Foundation of Fujian Province
- Fujian Medical University
- National Natural Science Foundation of China
Zitieren
APA
Yu, S., Wei, H., Li, J., Wang, Q., Yuan, X., Wu, Z., & Fang, X. (2026). Pomolic acid suppresses osteosarcoma growth and metastasis through the TNF/NF-κB-autophagy axis. Pathology - Research and Practice, 285, 156525. https://doi.org/10.1016/j.prp.2026.156525
Vancouver
Yu S, Wei H, Li J, Wang Q, Yuan X, Wu Z, et al. Pomolic acid suppresses osteosarcoma growth and metastasis through the TNF/NF-κB-autophagy axis. Pathology - Research and Practice. 2026;285:156525. doi:10.1016/j.prp.2026.156525
BibTeX
@article{Yu2026,
author = {Yu, Shaolin and Wei, Hongxiang and Li, Jiayu and Wang, Qijin and Yuan, Xuhui and Wu, Zhaoyang and Fang, Xinyu},
title = {Pomolic acid suppresses osteosarcoma growth and metastasis through the TNF/NF-κB-autophagy axis},
journal = {Pathology - Research and Practice},
year = {2026},
volume = {285},
pages = {156525},
doi = {10.1016/j.prp.2026.156525}
}
EUVIMED